Share & Earn


The State of Diabetes Care According to Joslin, 100 Years After the First Human Insulin Shot

0 2 years ago

A graphic timeline stretches down that hallway, sharing — over and over — breakthroughs in diabetes care that originated there. From the early pioneering efforts of Dr. Elliot Joslin to simply keep people with diabetes alive, to (almost exactly 100 years ago) the first insulin shots being administered to human patients, to breakthroughs in treatment and advances in how and why care is delivered, this legendary research and care center has long been at the lead.

This year, with CEO Dr. Roberta Herman at the helm and a new partnership with Cambridge, Massachusetts-based Beth Israel Leahy Health (BILH), Joslin hopes to not just honor that history, but to continue progress towards better treatment, less stressful access, and of course, an eventual cure.

Joslin is the world’s largest diabetes research center, diabetes clinic, and provider of diabetes education. It employs 600 people and has satellite clinics across Massachusetts, Maryland, Illinois, and New Jersey. BILH has more than 4,800 physicians and 36,000 employees.

“Together, we are a powerhouse of metabolic research,” Herman told DiabetesMine.

Herman, who lost her mother to a chronic disease at a young age as a child, has worked over the years in leadership roles in primary care, and later as chief operating officer of Harvard Pilgrim Health Care, one of the nation’s largest insurers. She took over leadership of the Joslin Diabetes Center in January 2020, in the midst of the COVID-19 pandemic.

Click Here to read the full version of this great article

Leave a Comment

Your email address will not be published. Required fields are marked *